Skip to content
Menu

Sanofi, Pan-Canadian Pharmaceutical Alliance Sign Letter Of Intent For Sarclisa

Benzinga Newsdesk 10 hours ago

NewsFDA

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Agreement paves the way for newly diagnosed, transplant-ineligible patients fighting multiple myeloma to access first-line treatment Sarclisa® through provincial and territorial cancer treatment formulary listings.

Read at benzinga.com